Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics.
10.15430/JCP.2016.21.4.209
- Author:
Ji Young CHA
1
;
Ho Jae LEE
Author Information
1. Department of Biochemistry, Gachon University College of Medicine, Incheon, Korea. hojlee@gachon.ac.kr
- Publication Type:Review
- Keywords:
Lipid metabolism;
Lipogenesis;
Cancer;
Therapeutics
- MeSH:
Lipid Metabolism;
Lipogenesis;
Membranes;
Metabolic Networks and Pathways;
Metabolism
- From:Journal of Cancer Prevention
2016;21(4):209-215
- CountryRepublic of Korea
- Language:English
-
Abstract:
Cancer cells rewire their metabolism to satisfy the demands of growth and survival, and this metabolic reprogramming has been recognized as an emerging hallmark of cancer. Lipid metabolism is pivotal in cellular process that converts nutrients into energy, building blocks for membrane biogenesis and the generation of signaling molecules. Accumulating evidence suggests that cancer cells show alterations in different aspects of lipid metabolism. The changes in lipid metabolism of cancer cells can affect numerous cellular processes, including cell growth, proliferation, differentiation, and survival. The potential dependence of cancer cells on the deregulated lipid metabolism suggests that enzymes and regulating factors involved in this process are promising targets for cancer treatment. In this review, we focus on the features associated with the lipid metabolic pathways in cancer, and highlight recent advances on the therapeutic targets of specific lipid metabolic enzymes or regulating factors and target-directed small molecules that can be potentially used as anticancer drugs.
